69 Best Biotech Startups to Watch in 2024

Vonafexor drug maker for the treatment of Alport syndrome.

Total Raised: $110.47M

Last Funding: $42.57M (Series C)

Developer of prophylactic vaccine against Group B Streptococcus.

Total Raised: $176.61M

Last Funding: $53.26M (Debt Financing)

Oophthalmic gene therapy company to treat blinding retinal illnesses.

Total Raised: $120.86M

Last Funding: $120.86M (Series A)

ITM Isotopen Technologien Munchen is a Munich-based developer of personalized cancer diagnostic solutions.

Total Raised: $205.00M

Last Funding: $205.00M (Series D)

Antibody-drug conjugate (ADC) payload platform.

Total Raised: $115.00M

Last Funding: $115.00M (Series A)

Formo is a manufacturer of animal-free cheese alternative products founded in 2019 by Raffael Wohlgensinger.

Total Raised: $111.50M

Last Funding: $45.80M (Series A)

Oral antifungal therapy developer to treat life-threatening rare fungal infections

Total Raised: $170.00M

Last Funding: $100.00M (Series D)

Short-duration psychedelic medicines developer for neuropsychiatric conditions.

Total Raised: $43.69M

Last Funding: $40.00M (Series B)

Nuclera is a provider of eProtein discovery benchtop system founded in 2013 by Jiahao Huang, Gordon McInroy and Michael Chen.

Total Raised: $117.50M

Last Funding: $75.00M (Series C)

Developer of immunoglobulin E (IgE) antibodies to treat cancer.

Total Raised: $64.47M

Last Funding: $16.50M (Series B)

Developer of neurostimulation system to treat swallowing dysfunction.

Total Raised: $52.10M

Last Funding: $42.00M (Series D)

Developer of full-spectrum microbial therapeutics.

Total Raised: $51.27M

Last Funding: $0.63M (Seed)

Drug discovery platform for fibrotic diseases.

Total Raised: $196.67M

Last Funding: $100.66M (Series C)

Advanced allosteric modulator therapeutics developer for neurological disorders.

Total Raised: $63.00M

Last Funding: $63.00M (Series A)

iRhom2 antibodies developer for better treatment of autoimmune diseases.

Total Raised: $68.25M

Last Funding: $68.25M (Series A)

Small molecule MKK4 inhibitors to treat acute and chronic liver diseases

Total Raised: $37.60M

Last Funding: $16.00M (Series C)

Gene therapies developer for pediatric patients.

Total Raised: $52.00M

Last Funding: $52.00M (Series B)

Lumicks is a drug discovery platform for cancer founded in 2014 by Gerrit Sitters .

Total Raised: $114.90M

Last Funding: $21.90M (Debt Financing)

Inbrain Neuroelectronics is a developer of brain-computer interface therapeutics (BCI-Tx founded in 2020 by Carolina Aguilar.

Total Raised: $68.10M

Last Funding: $50.00M (Series B)

Basecamp Research is an AI-driven protein sequences and biological systems developer founded in 2019 by Glen Gowers.

Total Raised: $80.00M

Last Funding: $60.00M (Series B)

Constructive Bio is a synthetic genome editing platform for biopharmaceuticals industry founded in 2021 by Jason Chin.

Total Raised: $73.00M

Last Funding: $58.00M (Series A)

Developing next generation ‘biopesticides’ based on natural microorganisms.

Total Raised: $93.65M

Last Funding: $76.90M (Series C)

Novel antiobiotic researcher to fight antimicrobial resistance.

Total Raised: $34.47M

Last Funding: $13.57M (Series C)

Clinical-stage central nervous system (CNS) technology.

Total Raised: $169.29M

Last Funding: $110.29M (Series B)

Elicit Plant is a biosolutions provider for broadacre crops founded in 2017 by Jean-Francois Jeff Déchant.

Total Raised: $66.00M

Last Funding: $48.00M (Series B)

Developer of MEM-ANT3310, a next generation antibacterial combination.

Total Raised: $35.86M

Last Funding: $1.00M (Seed)

Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).

Total Raised: $36.94M

Last Funding: $24.00M (Series B)

Portfolio of pharmaceutical research and discovery.

Total Raised: $33.50M

Last Funding: $33.50M (Series C)

AI-driven drug discovery platform for rare diseases.

Total Raised: $47.00M

Last Funding: $47.00M (Series C)

Brenus Pharma is a cancer vaccine developer founded in 2021 by Benoit Pinteur.

Total Raised: $29.50M

Last Funding: $25.00M (Series A)

Advanced bio-based ingredients manufacturer.

Total Raised: $35.00M

Last Funding: $15.00M (Seed)

Producer of ethanol-free perfume pearls.

Total Raised: $16.07M

Last Funding: $10.44M (Series A)

Animal-free dairy protein.

Total Raised: $20.15M

Last Funding: $4.20M (Seed)

Clinical-stage research for alzheimer’s disease.

Total Raised: $66.45M

Last Funding: $58.65M (Series A)

Discovery and development platform of superior microbial bioproducts.

Total Raised: $7.20M

Last Funding: $0.46M (Seed)

Platform for advancing neuroscience and neurophysiology solutions.

Total Raised: $9.11M

Last Funding: $2.66M (Seed)

Therapeutic device developer focused on treating structural heart disease.

Total Raised: $15.50M

Last Funding: $13.00M (Series A)

Drug discovery and development platform.

Total Raised: $8.65M

Last Funding: $1.00M (Seed)

Cryotherapy system focused on development, clinical benefit demonstration, and commercialization.

Total Raised: $10.77M

Last Funding: $10.77M (Series B)

Interceptive therapies for heart failure subpopulations.

Total Raised: $82.41M

Last Funding: $69.61M (Series A)

Non-coding RNA-based therapeutics.

Total Raised: $21.58M

Last Funding: $10.66M (Seed)

Naturbeads is a sustainable and biodegradable cellulose ingredients producer founded in 2018 by Giovanna Laudisio.

Total Raised: $11.59M

Last Funding: $9.85M (Series A)

Cell therapy development paltform.

Total Raised: $18.21M

Last Funding: $18.21M (Series A)

Gene-editing platform.

Total Raised: $50.83M

Last Funding: $18.00M (Series A)

Computational drug discovery platform.

Total Raised: $37.00M

Last Funding: $37.00M (Series B)

Peptides for the treatment of rare endocrine and related diseases.

Total Raised: $138.63M

Last Funding: $138.63M (Series C)

Clinical stage treatment for Myotonic Dystrophy Type 1

Total Raised: $46.32M

Last Funding: $46.32M (Series B)

Bispecific complement engaging (BiCE™) platform.

Total Raised: $17.18M

Last Funding: $17.18M (Seed)

Cancer immunotherapy researcher.

Total Raised: $26.27M

Last Funding: $10.60M (Seed)

Oncology drug discovery platform.

Total Raised: $11.43M

Last Funding: $11.43M (Seed)

Gene therapies for inherited retinal disorders.

Total Raised: $65.19M

Last Funding: $65.19M (Series A)

Chemical discovery digitisation platform.

Total Raised: $42.93M

Last Funding: $42.93M (Series A)

Mycoprotein ingredient producer.

Total Raised: $13.10M

Last Funding: $13.10M (Series A)

RNA sequencing platform.

Total Raised: $10.79M

Last Funding: $10.79M (Seed)

Preclinical biotech company developing technology for the treatment of eye diseases.

Total Raised: $7.00M

Last Funding: $7.00M (Seed)

Manufacturer of medical cannabis medicines.

Total Raised: $7.25M

Last Funding: $7.25M (Series A)

International advisory firm for healthcare sector.

Total Raised: $93.00M

Last Funding: $58.00M (Series C)

Cannabis-based medicines developer.

Total Raised: $21.54M

Last Funding: $21.54M (Series B)

Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.

Total Raised: $127.76M

Last Funding: $15.90M (Series C)

Treatment for severe neuromuscular disorders.

Total Raised: $165.73M

Last Funding: $81.61M (Series B)

Amphistar is a sustainable biosurfactant products producer founded in 2021 by Sophie Roelants , Bernd Everaert and Karolien Maes .

Total Raised: $8.50M

Last Funding: $2.20M (Unknown)

Natural aromas producer for food and beverage industries.

Total Raised: $8.97M

Last Funding: $7.60M (Series A)

Technology to transform human urine into an alternative to agricultural fertilizer.

Total Raised: $11.89M

Last Funding: $0.10M (Seed)

Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.

Total Raised: $13.66M

Last Funding: $0.66M (Unknown)

MiLaboratories is a bioinformatics solutions to probe adaptive immunity founded in 2021 by Stanislav Poslavsky.

Total Raised: $12.30M

Last Funding: $10.00M (Series A)

Manufacturing platform designed to help patients access lifesaving treatments.

Total Raised: $130.00M

Last Funding: $100.00M (Series B)

Producer of gut health binding proteins.

Total Raised: $41.22M

Last Funding: $32.80M (Series A)

Therapeutic protein developer for chronic neuropathic pain.

Total Raised: $26.76M

Last Funding: $24.76M (Series A)

Gene and cell therapy manufacturing.

Total Raised: $50.42M

Last Funding: $50.42M (Series A)